53 related articles for article (PubMed ID: 9266944)
1. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate.
Porcu P; Danielson CF; Orazi A; Heerema NA; Gabig TG; McCarthy LJ
Br J Haematol; 1997 Aug; 98(2):433-6. PubMed ID: 9266944
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study.
Lee H; Han JH; Kim JK; Yoo J; Cho HS; Yoon JH; Cho BS; Kim HJ; Lim J; Jekarl DW; Kim Y
J Clin Apher; 2023 Dec; 38(6):727-737. PubMed ID: 37786990
[TBL] [Abstract][Full Text] [Related]
4. Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice.
Wolf J; Thomas I; Stanworth S; Knapper S; Griffin J
Transfus Med; 2023 Apr; 33(2):181-187. PubMed ID: 36260030
[No Abstract] [Full Text] [Related]
5. Management of hematological patients requiring emergency chemotherapy in the intensive care unit.
Lafarge A; Chean D; Whiting L; Clere-Jehl R; ;
Intensive Care Med; 2024 Jun; 50(6):849-860. PubMed ID: 38748265
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular collapse and McConnell's sign as early manifestations of leucostasis.
Rozenbaum D; Lebold KM; Lee D; Salmi D; Htet NN
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38367997
[TBL] [Abstract][Full Text] [Related]
7. T-cell Acute Lymphoblastic Leukemia in Crisis: Hyperleukocytosis, Tumor Lysis Syndrome, and Innovative Approaches.
White G; Duchow M; Amar L
Cureus; 2024 Jan; 16(1):e52017. PubMed ID: 38344604
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis.
Farid KMN; Sauer T; Schmitt M; Müller-Tidow C; Schmitt A
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201486
[TBL] [Abstract][Full Text] [Related]
9. Acute vision loss due to CML leukemic retinopathy reversed with leukapheresis.
Leong S; Do T; Shodiya M; Lee J
Clin Case Rep; 2023 Jun; 11(6):e7441. PubMed ID: 37273676
[TBL] [Abstract][Full Text] [Related]
10. Repeated small-volume exchange transfusion for hyperleukocytosis in pediatric acute leukemia: A retrospective analysis.
Zhang D; Lin H; Huang L
Front Pediatr; 2023; 11():1155481. PubMed ID: 37033185
[TBL] [Abstract][Full Text] [Related]
11. Leukapheresis and Hyperleukocytosis, Past and Future.
Zhang D; Zhu Y; Jin Y; Kaweme NM; Dong Y
Int J Gen Med; 2021; 14():3457-3467. PubMed ID: 34285568
[TBL] [Abstract][Full Text] [Related]
12. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis.
Haas NL; Nafday A; Cranford JA; Yentz SE; Bixby DL; Bassin BS
Crit Care Explor; 2020 Feb; 2(2):e0084. PubMed ID: 32211616
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.
Shallis RM; Stahl M; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukhereje S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
Leuk Lymphoma; 2020 May; 61(5):1220-1225. PubMed ID: 32100599
[No Abstract] [Full Text] [Related]
15. Recommendations for Therapeutic Apheresis by the Section "Preparative and Therapeutic Hemapheresis" of the German Society for Transfusion Medicine and Immunohematology.
Worel N; Mansouri Taleghani B; Strasser E
Transfus Med Hemother; 2019 Dec; 46(6):394-406. PubMed ID: 31933569
[TBL] [Abstract][Full Text] [Related]
16. Sepsis-induced Hyperleukocytosis in a Preterm.
Alatassi EU; Sukkar M; Garrada FN
Cureus; 2019 Sep; 11(9):e5594. PubMed ID: 31700707
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia patient with
Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
[No Abstract] [Full Text] [Related]
18. Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India.
Tendulkar AA; Jain PA; Gupta A; Sharma N; Navkudkar A; Patle V
Asian J Transfus Sci; 2017; 11(2):156-161. PubMed ID: 28970685
[TBL] [Abstract][Full Text] [Related]
19. Neurological Complications of the Leukemias Across the Ages.
Berg S; Nand S
Curr Neurol Neurosci Rep; 2017 Feb; 17(2):13. PubMed ID: 28229399
[TBL] [Abstract][Full Text] [Related]
20. Management of Hyperleukocytosis.
Ruggiero A; Rizzo D; Amato M; Riccardi R
Curr Treat Options Oncol; 2016 Feb; 17(2):7. PubMed ID: 26820286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
